Phosphorylation and inactivation of HMG-CoA reductase at the AMP-activated protein kinase site in response to fructose treatment of isolated rat hepatocytes  by Gillespie, John G. & Hardie, D.Grahame
Volume 306, number I, 59-62 FEBS 11261 
Q 1992 Federation of European Biochemical Societies 00145793/92/S5.00 
July 1992 
Phosphorylation and inactivation of HMG-CoA reduztase at the 
AMP-activated protein kinase site in response to fructose treatment of 
isolated rat hepatocytes 
John G. Gillespie and D. Grahame Hardie 
Depparrtwtt of l3fochctttistry. The ihiversiiy. Dutrdeec DDf 4fiN, Scotfatrd, UK 
Received IS May 1992 
We have prcvious!y shown that inc.rbation of isolated hcpatocytcs with fructose leads to elevation of AMP and activation of the AMP-activated 
protein kinase. We now show that this treatment causes marked inactivation of HMGCoA rcductasc. Using immunoprccipitntion from the 
microsomal fraction of “P-labcllcd cells, we also show that this treatment leads to a 2.6.fold incrcasc in IIIC phosphorylation ofthe 100 kDa subunit 
of HMG-CoA rcductase. Successive digestion of this 3zP-labcllcd subunit with cyanoecn bromide and endoproteinasc Lys-C confirmed that Ser.871, 
the site phosphorylalcd in cell&ee assays by the AMP-activated protein kinase. was the only site phosphorylated under these conditions. 
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I. INTRODUCTION 
The principal regulatory step in the biosynthetic 
pathway of cholesterol and other isoprenoid com- 
pounds, the conversion of HMG-CoA to mevalonate, 
is catalysed by HMG-CoA reduc?asc. This enzyme is 
subject o complex multivalent control mechanisms [I], 
including acute regulation of the activity of the enzyme 
by reversible phosphorylation [3]. Several protein ki- 
nases phosphorylate and inactivate HMG-CoA reduc- 
tase in cell-free assays, including the AMP-activated 
protein kinase (formerly termed HMG-CoA rcductase 
kinasc) [3,43, protein kinase C [S] and a calmodulin- 
activated protein kinase [6]. The AMP-activated protein 
kinase is the major Ca”‘-independent HMG-CoA re- 
ductase kinase in rat liver [4] and appears to have a 
general role in the regulation of lipid metabolism [2]. 
This kinase is activated allosterically by AMP, which 
also promotes its further activation due to phosphoryl- 
ation by a distinct kinase i-71. Recently we have demon- 
strated that the AMP-activated protein kinase [S’J, pro- 
tein kinase C and calmodulin-dependent multiprotein 
kinase [9] all phosphorylate a single identical site on 
HMG-CoA reductase, corresponding to Ser-871 in the 
hamster enzyme (Ser-872 in the human sequence). This 
site is phosphorylated in intact rat liver under condi- 
tions where HMG-CoA reductase is largely in the inac- 
tive form [8]. We now show that this site also becomes 
phosphorylated when AMP is elevated in intact rat 
hepatocytes, and that this is the only site 
phosphorylated on the 100 kDa subunit under these 
conditions. Increased phosphorylation at this site is as- 
sociated with a marked inactivation of HMG-CoA re- 
ductase. 
2. MATERIALS AND METHODS 
3. I. Murrriuls 
[“C]HMG-CoA and [‘?P]phosphate wcrc from Amcrsham Inlerna- 
tional, and ~H]mevalonolactonc from New England Nuclear. Leu- 
peptin was from The Peptidc Institute, Japan. Twccn-20 was from 
Bio-Rad. Nitrocellulosewas from Schlcicher &Schuell. HEPES, man- 
nitol. NADP, Slucose~G-phosphate dchydrogcnase, sodium dodecyl 
sulfate, deoxycholic acid (Na salt), Triton X-100, and iodoacctamidc 
were from Sigma, Dorset, UK. Digitonin (high purity) from Calbio. 
them was further puriftcd as described [IO]. Sourcesofothcr malerials 
have been previously dcscribcd [4,7.8]. 
2.2. Isofalion ortd hcuba/ion o/cefls 
Before hepatocytc isolation, male rats wcrc fed for 6 days on stand- 
ard laboratory chow supplemented with 2% (by mass) cholcstyraminc. 
For the last 2 days, the diet was also supplemented with 0.2% (by mass) 
symvastatin. Hcpatocytes were isolated and incubated at 100 mg wcl 
wt./ml as previously described [7]. Cells wcrc pm-incubated 90 minules 
before addition of fructose (2 M, in incubation medium). For “P- 
labeling (0.25 mCi/ml), the phosphate concentration i the medium 
was reduced to 0.2 mM. 
2,3. Irrrrttrtrtop~ecipitut~ett o/J~P-fulwffed HM’G CuA rcdocrose 
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2OlOG3. 
To minimize phosphorylation of HMG-CoA rcductase during har- 
vesting of cells, 16 ml aliquots of cell suspnsion were diluted with 35 
ml of ice-cold Krebs-Henscleit buffer before ccntrifugation [I 11. They 
were rcsuspcnded in 4 ml oficc-cdd hypotonic homogcnisation bulTer 
(50 mM TWHCI, pH 7.2. at 4% I mM EGTA, I mM EDTA, 1 mM 
dithiothrcitol, SO mM NaF, 1 mM Na pyrophosphate, with the follow- 
ing proteinasc inhibitors: I mM phcnylmethane sulphonyl fluoride. 
0. I mM Ieupeptin, 0. I mM TPCK, Q.1 mM TLCK, 0.1 mM bcnzamid- 
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inc. und 0.1 mM soybean trypsin inhibitor), and homogeniscd \vith 40 
strokes of a ground-glass homogcniscr. 1 ml orhomogenisution bul’l’er 
conluininy 125 M SZCrosC :‘,‘nS 2 dded, the homogenate centrifuged 
(lB,OOOxg, 15 min. 4°C). rind the supernatant rccentriruged 
(lOO,OOOxg, 4OC). The niicrosomal pellet was resuspended in 1 ml of 
immunoprecipitation butler (I% (v/v) Triton X-100, 0.5% (w/v) de- 
oxycholate. 0.1% (w/v) sodium dodecyl sulphate. 20 mM HEPES, pH 
‘1.2, 50 mM NoF, 50 mM NuCI, 5 mM EDTA. 5 mM EGTA. plus 
proteinasc inhibitors as berore) and IO II of rabbit anti-HMG CoA 
reductase serum added. Alter incubation on ice for 60 min, 40 ,uI of 
protein A-agnrose was added, and incubation continued for GO min 
with gentle orbital shaking. Immune complexes were recovered by 
centrilItgation (12,OOOxg. IO s. 4°C). lmmunoprecipitates were analy 
sed on 5- 15% polyacrylamidc gradient gels as described previously [S]. 
2 -4. Pl~o.splwp~~pr irk mrfpis o/’ ‘:P-lobektl HMG-Co,4 reflfrcrask 
Th: purified 53 kDa liqment or rat liver HMG CoA reductasc was 
phosphorylated using [$?]ATP and purified AMP-activated protein 
kinase as previously clrscribed [8]. HMG-CoA rcductasc was also 
imrnunoprecipitatcd from ?‘P-labelled cells, purified by SDS-PAGE, 
and transferred to nitrocellulose using a Bio-Rud Tranablot appara- 
tus. The 100 kDa subunit was located on a Molecular Dynamics 
Phosphorimagcr, excised, and elutcd from the nitrocellulosc using 
70% formic acid. The ‘:D-Isbelled 53 kDa IIagnlent or 100 kDa sub- 
unit wcrc then subjected to successive digestion wth CNBr and en- 
doproteinssc Lys-C. and anslysed by thin-layer isoelectric focussing 
[S]. Labclled peptidcs wet-c dctccted on a Molecular Dyriamics 
Phosphorimager. 
AMP-activated protein kinase was partially purified from hcpato- 
cytc suspensions by polycthylcnc glycol precipitation and assayed as 
previously described [7]. HMG-CoA reductase was assayed (4 min. 
37°C) in siw in digitonin-permeabiliscd hepatocytes [12] except that 
we used 50 ,~g digitonin per mg ccl1 protein, 472.5 mlJ ylucose-G- 
phosphate dehydrogenaac, nnd 10,000 dpnl/nmol [?]HMG-CoA. 
Imnu~nodetcction or imrnunoprecipitated HMG-CoA reductuse that 
had been clectroblotted to nitrocellulose was carried out as follows, 
with all reagents being diluted in TBS.Twcen (2.5 mM Tris/HCI, pH 
7.5, at 2O’C, 150 N&I, 0,058 (v/v)Tween-20) The blot was incubated 
successively for I h each in 3% (w/v) low&t milk powder. sheep 
anti-HMG-CoA reductasc IgG (50pgIml) plus 1% (w/v) milk powder, 
0.25% (v/v) biotinylatcd donkey anti-sheep IgG plus 1% (w/v) milk 
powder, and 0.25% (byvol.)streptavidin-biotinylated horseradish per- 
oxidase complex plus 18 (w/v) milk powder. Between each incubation 
the blot was washed live times for 5 min with TBS-Twccn. HMG-CoA 
reductuse was visualised using the ECL detection kit (Amcrsham). 
Protein concentrations wcrc measured by the dye-binding method of 
Bradford [ 131. 
3. RESULTS 
3.1. EJfect offr.nctose otl HMG-CoA rednctase activity 
As reported previously [7], treatment of isolated rat 
hepatocytes with 20 mM fructose caused a transient 
activation of the AMP-activated protein kinase, reach- 
ing a peak at 5-15 min and then slowly reverting to the 
control activity (Fig. 1B). We assayed HMG-CoA re- 
ductase in the same cells, using a method in which the 
enzyme is measured in situ in digitonin-permeabilized 
cells [12]. As expected, fructose treatment caused a re- 
ciprocal change in HMG-CoA reducrase activity. The 
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Fig. I. (A)HMG-CoA reductase activity and (B) AMP-activated pro- 
tein kinase activity in hcpatocyte xtracts made at various times after 
addition of fructose to the cells, Similar results were obtained in three 
other experiments. 
low up to 20 min, and then reverted to a value at or 
above the control (Fig. 1). 
3.2. l?fitct ofjwtose 012 phosphrylariott of HMG-CoA 
reductasc 
Hepatocytes were labelled for 90 min with [‘?P]phos- 
phate before trea:ment with or without fructose for 10 
min. HMG-CoA reductase was purified by immunopre- 
cipitation using rabbit antibodies raised against he 53 
kDa fragment of the enzyme, followed by SDS-PAGE 
and transfer to nitrocellulose. Fig. 2 (panel A) shows 
that fructose caused a marked stimulation of 3ZP-la- 
belling of the 100 kDa polypeptide of HMG-CoA re- 
ductase. In six separate xperiments he increase in 3ZP- 
labelliag of the 100 kDa subunit was 2.6 f 0.6-fold 
(mean ?Z S.E.M., PcO.05). The polypeptide of 120 kDa, 
whose 3ZP-labelling was also increased by fructose, ap- 
peared to be unrelated to HMG-CoA reductase because 
it was also precipitated with control serum (not shown) 
and was not consistently observed. In some experiments 
(e.g. panel B) the antibody also precipitated polypep- 
tides which migrated in the range 50-60 kDa, and for 
which 3’P-labelling was also increased after fructose 
treatment. The proteolytic fragments of HMG-CoA re- 
ductuse are known to migrate in this region [14], and 
variable amounts of these polypeptides were observed, 
despite the use of a battery of proteinase inhibitors. 
Since we needed to br sure that the increased labelling 
of the 100 kDa subunit was not mereiy due to different 
degrees of proteolysis, we also probed the blots using 
sheep antibodies distinct from those used for im- 
munoprecipitation. Panel C shows that both the 100 
and 60 kDa polypeptides were recognized by this anti- 
60 
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Fig. 2, (A.B) Autoradiograms and (C) immunoblot of immunoprccip- 
hates from 3~P-labelled cells which had been treated with (F) or with- 
out (C) fructose. Anti-HMG-CoA reductase immunoprccipitatcs 
made using rabbit anlibodies were annlysed by SDS-PAGE and trans- 
ferred to nitrocellulose before detection using autoradiography (A,B) 
or sbecp ami-HMG-CoA reductase antibodies(C). Panels A and Bare 
separate experiments; panels B and C are the same nitroccllulose blot. 
body, but that the recovery of the 100 kDa subunit :v~s 
identical in the two samples. There was some evidence 
that further degradation of tilt: 60 kDa fragments to 
smaller fragments not recognized by the sheep antibody 
was increased in the samples from fructose-treated cells. 
to frtrctose 
The area of nitrocellulose containing the “‘P-labelled 
100 kDa subunit from an experiment similar to that 
shown in Fig. 2A was excised, and the polypeptide 
eluted with formic acid. The polypeptide was then sub- 
jected to successive digestions with cyanogen bromide 
and endoproteinase Lys-C. As a marker, a sample of the 
purified 53 kDa fragment of rat liver HMG-CoA reduc- 
tase was phosphorylated using [y-3’P]ATP and purified 
AMP-activated protein kinase and analysed in the same 
way. We have shown previously that this procedure 
generates from the 53 kDa fragment a single 3’P-labelled 
peptide with the sequence, VHNRSK, containing the 
serine residue equivalent to Ser-871 on the hamster en- 
zyme [8]. The two samples were run side-by-side on thin 
layer isoelectric focussing. Fig. 3 (lane 2) shows that the 
sample OF 53 kDa fragment phosphorylated by the 
AMP-activated protein kinase generated a major 
phospbopeptide with the same pI(6.5) as the VHNRSK 
peptide analysed previously [S], plus two minor acidic 
phosphopeptides. The 100 kDa subunit from “P-la- 
belled, fructose-treated cells yielded only a single 
phosphopeptide (Fig. 3, lane l), which exactly co-mi- 







Fig. 3. Thin-layer isoelectric focussing of a CNbrIendoproteinaae Lys- 
C digest of ‘?P-labelled HMG-CoA reductase. (Lane I) 100 kDa sub- 
unit from fructose-treated (IO min) ‘*P-labelled hepalocytea; (lane 2) 
the 53 kDa catalytic fragment phosphorylated using [Y_~‘P]ATP and 
purified AMP-activated protein kinase. Labeled peptides were dc- 
tected on a Molecular Dynamics Phosphorimager. The isoelectric 
point (pl) scale, which is a rough guide only, was drawn by compari- 
son with the mobility of colourcd marker proteins. 
4. DISCUSSION 
To our knowledge this paper represents for the first 
time that phosphorylation of the 100 kDa subunit of 
HMG- CoA reductase has been demonstrated directly 
by 3ZP- labelling in intact cells, although Beg et al. [6] 
reported “P labelling of the 53 kDa fragment in rats 
injected with [‘“P]phosphate. Our results provide strong 
evidence that the AMP-activated protein kinase is a 
physiological regulator of HMG-CoA reductase. Incu- 
bation of rat hepatocytes with 20 mM fructose causes 
a large fall in ATP and concomitant rise in AMP level 
in the cell [7]. This is thought to be due to the trapping 
of phosphate as esters of fructose and trioses, which 
inhibits resynthesis of ATP from ADP, and leads to 
conversion of ADP to AMP via adenylate kinase [16]. 
These effects are transient, and normal nucleotide levels 
are regained once the fructose is metabolized. Correlat- 
ing with the rise in AMP there is a dramatic but tran- 
sient activation of the the AMP-activated protein ki- 
nase, due to increased phosphorylation as well as allos- 
teric activation [7]. In this paper we show that this 
causes a marked reciprocal inactivation of HMG-CoA 
reductase (Fig. 1). Reactivation of HMG-CoA reduc- 
tase does not occur until the kinase activity has returned 
almost to the basal level (e.g. at 30 min in Fig. 1). This 
is similar to results obtained previously with acetyl-CoA 
carboxylase [7], and suggests that only a small activa- 
tion of the kinase is required in order to obtain complete 
conversion of acetyl-CoA carboxylase or HMG-CoA 
reductase to their inactive. phosphorylated forms. 
61 
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Fig. 2 shows that incubation with fructose for 10 min 
also caused a marked stimulation of phosphorylation of 
the 100 kDa subunit of HMG-CoA reductase, although 
the results of some experiments were complicated by 
degradation to the SO-60 kDa catalytic fragments. De- 
spite the inclusion of a battery of proteinase inhibitors 
in the homogenization medium, the proteolysis most 
likely occurred after homogenization rather than in the 
intact cells, becarrsc it was not observed in all experi- 
ments (e,g, Fig. 2.4). 
The results in Figure 3 show that the AMP-activated 
protein kinasc site is the only site phosphorylated in the 
100 kDa subunit under these conditions. On isoelectric 
focussing a single 32P-peptide was obtained which ex- 
actly co-migrated with the VNHRSK peptide obtained 
by phosphorylation of the 53 kDa fragment of HMG- 
CoA reductase using purified AMP-activated protein 
kinase. This peptide contains a single phosphorylatable 
residue, equivalent to Ser-871 in the hamster enzyme 
and Ser-872 in the human enzyme (the complete se- 
quence of the rat enzyme is not yet known) [S]. We have 
previously shown that this residue is phosphorylated in 
intact rat liver sampled under conditions (absence of 
cold- or freeze-clamping) which cause elevation of AMP 
[S]. However, the non-radioactive methods used in that 
analysis did not allow us to determine whether any 
other sites were phosphorylated. We can now be confi- 
dent that Ser-8711872 is the only major site 
phoephorylated on HMG-CoA reductase in rat hepato- 
cytes under these conditions. 
Ser-8711872 is also phosphorylated in cell-free assays 
by protein kinase C and calmodulin-dependent multi- 
protein kinase [9]. However, while the AMP-activated 
protein kinase is dramatically activated in response to 
fructose, there are no grounds for believing that the 
other two protein kinases would be. In addition, others 
have shown [17] that phorbol esters, which activate pro- 
tein kinase C, do not cause inactivation of HMG-CoA 
reductase in rat hepatocytes. Elevation of Ca” using 
ionophores or combinations of vasopressin plus glu- 
cagon do lead to inactivation of HMG-CoA reductase, 
but this is not blocked by calmodulin antagonists [ 171. 
making it unlikely that the effect is due to phosphoryla- 
tion by a calmodulin-dependent protein kinase. In fact 
Ca’+ ionophores caused elevation of AMP [17] and so 
the effect in that case may have been brought about by 
activation of the AMP-activated protein kinase. 
Taken together with previous results demonstrating 
inactivation of acetyl-CoA carboxylase in response to 
fructose treatment f7], these findings suggest hat one 
function of the AMP-activated protein kinase is as a 
type of stress response. Any treatment of the cells which 
causes a depletion of ATP, and consequent rise in AMP, 
would cause activation of the kinase and would tend to 
switch off both fatty acid and cholesterol synthesis, 
These two pathways are very active in rat liver, and 
represent major consumers of ATP and NADPH. 
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